![Barry R. Walker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barry R. Walker
Fondatore presso American Society of Hypertension
Profilo
Barry R.
Walker is the founder of American Society of Hypertension.
He worked as a Senior Vice President of Research & Development at Wyeth-Ayerst Research and as an Adjunct Associate Professor of Medicine at the University of Pennsylvania.
He also served as an Independent Non-Executive Director at Botanix Pharmaceuticals Ltd.
and as SVP-Regulatory & Clinical Development at Ceptaris Therapeutics, Inc. He holds a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Yale University.
Posizioni attive di Barry R. Walker
Società | Posizione | Inizio |
---|---|---|
American Society of Hypertension | Fondatore | 16/03/2011 |
Precedenti posizioni note di Barry R. Walker
Società | Posizione | Fine |
---|---|---|
University of Pennsylvania | Corporate Officer/Principal | - |
BOTANIX PHARMACEUTICALS LIMITED | Direttore/Membro del Consiglio | 19/08/2011 |
Wyeth-Ayerst Research | Direttore Tecnico/Scientifico/R&S | - |
Ceptaris Therapeutics, Inc.
![]() Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Consigliere Generale | 22/03/2011 |
Formazione di Barry R. Walker
The Trustees of Columbia University in The City of New York | Doctorate Degree |
Yale University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
Aziende private | 3 |
---|---|
Ceptaris Therapeutics, Inc.
![]() Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Health Technology |
Wyeth-Ayerst Research | |
American Society of Hypertension |
- Borsa valori
- Insiders
- Barry R. Walker